Recce Director to Retire as Options Offers Open
RCE: $0.335 +0.00% · MC: $113M
Recce Pharmaceuticals director Alistair McKeough will retire after the November 6 AGM and will not seek re-election; the company has withdrawn the related resolution, and Alan Dunton will take over as Audit and Risk Committee chair. A prospectus also opens offers of unlisted options linked to the earlier placement, including up to 10 million additional options if attaching options are exercised.

Comments